Effect of vildagliptin, a dipeptidyl peptidase 4 inhibitor, on cardiac hypertrophy induced by chronic beta-adrenergic stimulation in rats

BACKGROUND: Heart failure with left ventricular (LV) hypertrophy is often associated with insulin resistance and inflammation. Recent studies have shown that dipeptidyl peptidase 4 (DPP4) inhibitors improve glucose metabolism and inflammatory status. We therefore evaluated whether vildagliptin, a DP...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyoshi, Toru, Nakamura, Kazufumi, Yoshida, Masashi, Miura, Daiji, Oe, Hiroki, Akagi, Satoshi, Sugiyama, Hiroki, Akazawa, Kaoru, Yonezawa, Tomoko, Wada, Jun, Ito, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926272/
https://www.ncbi.nlm.nih.gov/pubmed/24521405
http://dx.doi.org/10.1186/1475-2840-13-43

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926272/
https://www.ncbi.nlm.nih.gov/pubmed/24521405
http://dx.doi.org/10.1186/1475-2840-13-43

Ejemplares similares